Liver transplant study for severe worsening liver failure
Part of Digestive system clinical trials.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You have been diagnosed with cirrhosis (scarring of the liver).
- You were hospitalized because your cirrhosis suddenly got worse and you were referred to a transplant team.
- Your case fits one of these transplant situations: listed with severe acute-on-chronic liver failure, or listed with advanced poor liver function, or being assessed but not ultimately listed.
- You (or a trusted person if you can’t speak for yourself) can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.
This study looks at people with liver cirrhosis who develop a sudden, severe worsening of their liver function (called acute-on-chronic liver failure). It aims to better understand this condition and how it affects patients in the intensive care unit, which could help improve care.
This study tests a new way to check donated livers that other transplant centers have turned down. The goal is to see if these livers can be safely used for people on the waiting list, potentially increasing the number of available organs.
This trial tests whether a special type of stem cell therapy can help people with severe liver failure (called ACLF) that is not caused by a virus. The treatment may help your liver recover and improve your overall condition.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
This study tests whether a special type of stem cell therapy (called mesenchymal stem cells) can help people with a severe liver condition called acute-on-chronic liver failure (ACLF). The goal is to see if this treatment can improve liver function and reduce the need for a liver transplant.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.